These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11475810)

  • 1. [Follow-up of 'medications and pregnancy' at the Midi-Pyrenees Pharmacovigilance Center'].
    Lemoine T; Lacroix I; Lapeyre-Mestre M; Montastruc JL; Damase-Michel C
    Therapie; 2001; 56(3):287-93. PubMed ID: 11475810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A 2-year evaluation of questions concerning "Drugs--Pregnancy" at the CRPV in Nantes March 1992--March 1994].
    Chiffoleau A; Veyrac G; Baudot S; Larousse C
    Therapie; 1995; 50(5):429-38. PubMed ID: 8571281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacovigilance seen by a selected group of general practitioners and of residents in the Midi-Pyrénées region].
    Pouget-Zago P; Lapeyre-Mestre M; Bagheri H; Montastruc JL
    Therapie; 1995; 50(5):459-62. PubMed ID: 8571286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Adverse drug reactions in pregnant women].
    Lacroix I; Cabou C; Montastruc JL; Damase-Michel C
    Therapie; 2007; 62(5):455-60. PubMed ID: 18206108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-marketing surveillance system for drugs in pregnancy--15 years experience of ENTIS.
    Schaefer C; Hannemann D; Meister R
    Reprod Toxicol; 2005; 20(3):331-43. PubMed ID: 15978773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pivmecillinam and adverse birth and neonatal outcomes: a population-based cohort study.
    Vinther Skriver M; Nørgaard M; Pedersen L; Carl Schønheyder H; Sørensen HT
    Scand J Infect Dis; 2004; 36(10):733-7. PubMed ID: 15513399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Birth outcome in women treated with azathioprine or mercaptopurine during pregnancy: A Danish nationwide cohort study.
    Langagergaard V; Pedersen L; Gislum M; Nørgard B; Sørensen HT
    Aliment Pharmacol Ther; 2007 Jan; 25(1):73-81. PubMed ID: 17229222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obstetric and perinatal outcomes in pregnancies associated with illicit substance abuse.
    Ludlow JP; Evans SF; Hulse G
    Aust N Z J Obstet Gynaecol; 2004 Aug; 44(4):302-6. PubMed ID: 15282000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inter-regional differences in dysthyroidism due to amiodarone: comparison of spontaneous notifications in Aquitaine, Midi-Pyrenees and Languedoc-Roussillon].
    Bagheri H; Lapeyre-Mestre M; Levy C; Haramburu F; Hillaire-Buys D; Blayac JP; Montastruc JL
    Therapie; 2001; 56(3):301-6. PubMed ID: 11475812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-trimester exposure to alprazolam.
    St Clair SM; Schirmer RG
    Obstet Gynecol; 1992 Nov; 80(5):843-6. PubMed ID: 1407925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacovigilance of self-medication].
    Montastruc JL; Bagheri H; Geraud T; Lapeyre-Mestre M
    Therapie; 1997; 52(2):105-10. PubMed ID: 9231503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of illicit drugs during pregnancy among mothers of premature infants.
    Vélez NM; García IE; García L; Valcárcel M
    P R Health Sci J; 2008 Sep; 27(3):209-12. PubMed ID: 18782964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of reports on "pregnancy and drugs" received during a period of 39 months by the Regional Pharmacovigilance Center, Lorraine (Nancy)].
    Hanesse B; Trechot P; el Kouch S; Pierfitte C; Royer R; Netter P
    Therapie; 1995; 50(5):471-2. PubMed ID: 8571291
    [No Abstract]   [Full Text] [Related]  

  • 14. [Adverse drug effect in pregnancy: evaluation at the Midi-Pyrénées center].
    Veronese L; Damase-Michel C; Montastruc JL
    Therapie; 1994; 49(5):473-5. PubMed ID: 7855778
    [No Abstract]   [Full Text] [Related]  

  • 15. [Follow-up of 151 pregnant women exposed to antidepressant treatment (MAOI excluded) during organogenesis].
    Brunel P; Vial T; Roche I; Bertolotti E; Evreux JC
    Therapie; 1994; 49(2):117-22. PubMed ID: 7817334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse pregnancy outcomes associated with maternal enalapril antihypertensive treatment.
    Tabacova S; Little R; Tsong Y; Vega A; Kimmel CA
    Pharmacoepidemiol Drug Saf; 2003 Dec; 12(8):633-46. PubMed ID: 14762979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prenatal exposure to psychoactive substances: results of NENUPHAR study].
    Lacroix I; Hurault C; Saivin S; Raoul V; Berrebi A; Souchet E; Desboeuf K; Montastruc JL; Damase-Michel C
    Therapie; 2007; 62(2):177-83. PubMed ID: 17582321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neonatal outcome after exposure to beta adrenergic blockers late in pregnancy].
    Cissoko H; Jonville-Béra AP; Swortfiguer D; Giraudeau B; Autret-Leca E
    Arch Pediatr; 2005 May; 12(5):543-7. PubMed ID: 15885543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy outcomes after maternal exposure to simvastatin and lovastatin.
    Pollack PS; Shields KE; Burnett DM; Osborne MJ; Cunningham ML; Stepanavage ME
    Birth Defects Res A Clin Mol Teratol; 2005 Nov; 73(11):888-96. PubMed ID: 16163683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low dose methotrexate in the first trimester of pregnancy: results of a French collaborative study.
    Lewden B; Vial T; Elefant E; Nelva A; Carlier P; Descotes J;
    J Rheumatol; 2004 Dec; 31(12):2360-5. PubMed ID: 15570635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.